Global strategic investors Suntory, Estrella Galicia, Apollo Hospitals and UPSA backed the round, joined by Birmingham-based Future Planet Capital Regional.
The recognition comes against a challenging funding backdrop for female-founded businesses in the UK, Melissa Snover, founder and CEO of Rem3dy Health, said, with all-female-founded teams continuing to receive only around 2% of total venture capital investment.
“Following a year of significant transformation and against one of the toughest fundraising environments in recent years, we are now in a strong position to scale globally,” she said.
“Our focus on automation, advanced manufacturing and AI-driven personalization is enabling us to redefine how consumers engage with their health — and also extend that innovation into new categories such as personalized health for pets.”
The raise follows a year for Rem3dy Health that saw revenues increasing 61% to £10.2 million, and will support growth across the US, MENA region and India.
Turning personalization into a global mainstream category
Nourished has sold more than 60 million personalized vitamin gummies worldwide and has expanded into over 35,000 retail locations since launching seven years ago. The company offers both ready-made gummy stacks for common health goals, such as immunity, energy, and sleep, and fully personalized 3D-printed gummies created from a short online health questionnaire.
As Snover noted, the investment will accelerate the company’s mission to make personalized health accessible at scale.
“For decades, healthcare and nutrition have largely operated on a one-size-fits-all model. We believe the future lies in solutions tailored not only to the individual, but increasingly to highly specific population segments and micro-cohorts,” Snover said. “This investment helps us build the infrastructure required to make that future commercially viable and globally accessible, moving personalized health from a niche concept to a mainstream reality.”
She noted that ‘AI will fundamentally reshape personalized nutrition’ by allowing industry to move beyond broad demographic recommendations and gain a much deeper understanding of individual variability.
“For the first time, we can analyse billions of data points across nutrition science, clinical research, genetics, biomarkers, lifestyle factors and health outcomes to identify patterns that would be impossible for humans to uncover alone,” she said.
She did however note that data alone is not enough, and that the next wave of innovation will come from turning data-driven insights into practical, evidence-based products that improve everyday health outcomes.
Rem3dy’s role is to bridge the gap between intelligence and execution, Snover explained.
“We expect AI to become the engine that powers increasingly adaptive and personalized health solutions, while our technology platform enables those insights to become reality,” she said.
Pet health as next frontier for personalized wellness
Snover explained that Rem3dy sees the pet category as a key investment area, viewing it as a ‘natural extension of the broader shift towards personalized wellness’.
“Consumers increasingly view companion animals as members of the family and are applying many of the same standards to pet health that they apply to their own wellbeing,” Snover said. “They are seeking higher-quality ingredients, more targeted nutritional support and solutions tailored to the specific needs of their pets.”
She added that technologies underpinning personalized human health—including AI-driven recommendations, health data analysis and precision manufacturing—also apply to companion animals, and as the science evolves, she expects pet nutrition to mirror human nutrition’s shift from generic formulations to personalized, preventative and outcome-focused solutions.
“We see significant opportunities to leverage our technology platform across both categories, helping to deliver a more precise and individualised approach to wellbeing for humans and their pets alike,” Snover said.
Personalized health demand is universal but adoption varies by region
Snover noted that as Rem3dy expands into markets including the US, MENA and India, it observes that demand for personalized health is remarkably universal, with consumers across regions increasingly seeking solutions tailored to their individual needs rather than average population-based approaches. What differs is the pathway to adoption, she explained.
“In the United States, we see strong demand driven by wellness, performance optimisation and longevity. Across MENA, there is significant momentum around health innovation and preventative wellbeing, supported by substantial investment in healthcare transformation,” she said.
“In India, rapid digital adoption, increasing health awareness and a growing middle class are creating a highly receptive environment for personalized solutions.”
The team’s approach is therefore to maintain a consistent scientific and technology platform globally while adapting how they engage with consumers in each market.
Health and nutrition industry heading toward real-time personalization
Snover noted that a future where recommendations are continuously updated using biomarkers, wearables and real-time health data are ‘nearer than many people realise’.
“The ability to collect health data is no longer the limiting factor. Consumers are already generating unprecedented amounts of information through wearables, digital health platforms, connected devices and increasingly sophisticated biomarker testing,” Snover said.
“The challenge now lies in interpreting that data accurately, understanding what is clinically meaningful, and translating it into recommendations that genuinely improve outcomes.”
She noted that in the coming years, health recommendations are likely to become increasingly dynamic, evolving alongside an individual’s biology, lifestyle and goals.
“Rather than receiving static advice, consumers will engage with systems that continuously learn, adapt and refine recommendations over time,” … said. “The key will be ensuring that this evolution remains grounded in robust science, validated evidence and measurable health outcomes.”
Snover forecasts that it won’t be long until personalized nutrition becomes the ‘expectation rather than the exception’.
“Today’s nutrition industry is still largely built around recommendations designed for the average person, yet there is no such thing as an average human,” she said. “As our understanding of biological variability continues to improve, consumers will increasingly expect products and recommendations tailored to their unique needs, preferences and health objectives.”
This will mean a greater convergence between nutrition, health monitoring, diagnostics and preventive healthcare, where personalized nutrition will become more adaptive, predictive and integrated into daily life, Snover explained.
“Ultimately, the distinction between healthcare and nutrition may become increasingly blurred, with both working together to help individuals maintain health rather than simply respond to illness,” she said.